Lifecore Biomedical, Inc. (LFCR) Stock

Lifecore Biomedical, Inc., alongside its subsidiaries, operates as a comprehensive contract development and manufacturing organization serving global markets. The company is structured into three main segments: Lifecore, Curation Foods, and Other. The Lifecore segment specializes in the production of pharmaceutical-grade sodium hyaluronate (HA) in bulk, along with the formulation and filling of syringes and vials for injectable products used across various medical applications. Lifecore also offers a range of services including technology development, analytical method development, formulation studies, stability assessments, and production for clinical trials, supporting both HA-based and non-HA-based products.

Additionally, Lifecore Biomedical's Curation Foods segment focuses on the processing, marketing, and distribution of gourmet food products. This includes olive oils and wine vinegars under the O brand, as well as guacamole and avocado food items marketed under the Yucatan and Cabo Fresh brands, among others. The company also provides these products under private labels, catering to diverse consumer preferences in the culinary market.

Originally incorporated as Landec Corporation in 1986, Lifecore Biomedical rebranded in November 2022 to better reflect its expanded focus and specialized expertise in biomedical and food product sectors. Headquartered in Santa Maria, California, Lifecore Biomedical continues to drive innovation and excellence in contract manufacturing and gourmet food processing, maintaining a strong commitment to quality and customer satisfaction.